A series of novel 1-piperidinesulfonylurea compounds derived from a nitrogen-containing monocarboxylic acid have been prepared by reacting an appropriate sulfamide with an organic isocyanate or a trisubstituted urea equivalent thereof. The sulfamylureas so obtained are useful in therapy as oral hypoglycemic agents. Typical members include those compounds derived from 2-methoxynicotinic acid, of which 1-(bicyclo[2.2.1]hept-5-en-2-yl-endomethyl)-3-4-[2-(2-methoxynicotinamido )ethyl]-1-piperidinesulfonyl}urea is a most preferred embodiment.
一系列新型1-
哌啶磺酰
脲类化合物由含氮单
羧酸与适当的磺酰胺与有机
异氰酸酯或三取代
脲等反应制备而成。所得的磺酰
脲类可用于治疗口服降血糖药物。典型成员包括从
2-甲氧基烟酸酸衍生的化合物,其中1-(双环[2.2.1]庚-5-烯-2-基-内甲基)-3-4-[2-(2-甲氧基烟酰胺)乙基]-1-
哌啶磺酰}
脲是最优选的实施形式。